Evidence map›Paper›PMID 29670837›Full record

ArticleAdvanced pharmaceutical bulletin2018

Assessing the Effect of High Performance Inulin Supplementation via KLF5 mRNA Expression in Adults with Type 2 Diabetes: A Randomized Placebo Controlled Clinical Trail.

Abed Ghavami, Neda Roshanravan, Shahriar Alipour, Meisam Barati, Behzad Mansoori, Faezeh Ghalichi, Elyas Nattagh-Eshtivan, Alireza Ostadrahimi

Open access · diamondAbstract read
In one paragraph

Article in Advanced pharmaceutical bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 4 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 4 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Roles of Krüppel-like factor 5 in kidney disease.Journal of cellular and molecular medicine · 2021
    Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Abed GhavamiDepartment of Nutrition, School of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.
Neda RoshanravanCardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Shahriar AlipourDepartment of Molecular Medicine, Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Meisam BaratiDepartment of Nutrition, School of Nutrition, Shahid beheshti University of Medical Sciences, Tehran, Iran.
Behzad MansooriImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Faezeh GhalichiDepartment of Nutrition, School of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.
Elyas Nattagh-EshtivanDepartment of Nutrition, School of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.
Alireza OstadrahimiNutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Tabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DiabetesFasting plasma glucoseInulinKLF5miR-375

Identifiers

PMID29670837
PMCPMC5896394
OpenAlexW2789691680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.